Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cimpress N.V. Ord (NQ: CMPR )

82.90 +0.74 (+0.90%)
Streaming Delayed Price Updated: 11:14 AM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cimpress N.V. Ord

< Previous 1 2 Next >
CMPR Stock Earnings: Cimpress Beats EPS, Beats Revenue for Q4 2024
CMPR stock results show that Cimpress beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
CMPR Stock Earnings: Cimpress Misses EPS, Misses Revenue for Q3 2024
CMPR stock results show that Cimpress missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024. 
Via InvestorPlace
Bull Of The Day: H&R Block
H&R Block’s fiscal third quarter is most crucial for the company as it leads up to the tax filing deadline which is typically April 15. 
Via Talk Markets
Is It Too Late to Buy Fiverr International Stock?
Fiverr's stock has soared more than 30% higher in recent weeks. Is there any room for further price gains? The answer might surprise you. 
Via The Motley Fool
Why Cimpress Stock Skyrocketed Today
The mass-customization company delivered a strong quarter and raised its full-year profitability guidance. 
Via The Motley Fool
Dow Jumps 250 Points; Honeywell Issues Weak Forecast
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Cimpress Q2 Earnings
Via Benzinga
Preview: Cimpress's Earnings
Via Benzinga
Preview: Cimpress's Earnings
Via Benzinga
What 4 Analyst Ratings Have To Say About Cimpress
Via Benzinga
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
Why Cimpress Stock Is Up After Earnings
Cimpress beat estimated earnings by 72.58%, reporting quarterly earnings of $2.14 per shares versus the analyst consensus estimate of $1.24. The company reported quarterly sales of $921.36 million... 
Via Benzinga
Analyst Ratings for Cimpress
Via Benzinga
A Preview Of Cimpress's Earnings
Via Benzinga
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&P 500 also rose,... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Chart Of The Day: Cimpress Seems To Be Printing Cash
Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. 
Via Talk Markets
Dow, Nasdaq Hold Triple-Digit Gains
The Dow Jones Industrial Average and Nasdaq Composite are both up triple-digits, despite this morning's GDP data which showed less economic growth than expected. 
Via Talk Markets
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... 
Via Benzinga
Lennox International, Meta Platforms, Hasbro And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. 
Via Benzinga
Iron Mountain Stock A Steady Eddie; Job 1: Data Protection
Iron Mountain stock boasts an outstanding 91 Composite Rating, showing that it's in the top 9% for technical and fundamental metrics. 
Via Investor's Business Daily
$1M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
Why Cimpress Stock Was Falling Today
Slowing revenue growth and declining profits weighed on the stock. 
Via The Motley Fool
Earnings Scheduled For January 25, 2023
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is expected to report quarterly earnings at $4.45 per share on revenue of $6.50 billion. 
Via Benzinga
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.